1. Market Research
  2. > Healthcare Market Trends

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Brazil

  • June 2017
  • 199 pages
  • GlobalData
Report ID: 1816889

Summary

Table of Contents

Search Inside

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Brazil

Summary
Brazil has one of the fastest growing pharmaceutical markets in the world. It is driven by an increasing disease burden and high affordability. However, a decrease in foreign investment and increased government promotion of generic drugs are barriers to growth. The value of the market was US$25.3 Billion in 2016, having increased from US$15.4 Billion in 2009 at a Compound Annual Growth Rate (CAGR) of 3.4%. Changing demographics are an important driver for the market, as the increasingly elderly population will lead to an increase in the incidence of chronic and other lifestyle-associated diseases. The growing middle class, who have high purchasing power, is another major driver.

Brazil’s medical device market was valued at US$7.1 Billion in 2009 and US$9.7 Billion in 2016. It is projected to grow at a CAGR of 6.4% from US$10.9 Billion in 2017 to US$14 Billion in 2021. In 2016, In Vitro Diagnostics (IVD) accounted for 11.5% of the medical device market, followed by orthopedic devices (10.8%), diagnostic imaging (10.6%), ophthalmic devices (8.8%) and cardiovascular devices (8.7%).

Most hospitals in Brazil offer primary care services exclusively. In 2016, health expenditure accounted for 8.2% of GDP, having accounted for 8.6% in 2009. Brazilian hospitals have inadequate resources and are thereby unable to provide access to healthcare provisions for every citizen, especially to those in weaker economic sections.

Brazil entered a period of recession in 2015. The economy contracted by 3.6% in 2016. This was due to a fall in commodity prices and political instability that led to a decline in investor confidence. This was augmented by the Chinese economic slowdown, which led to reduced demand for commodities and the corruption scandals involving government officials and major companies. In August 2016, following mass nationwide protests, President Rousseff was impeached on charges of breaking budgetary laws and the incumbent vice president Michel Temer took over.

The report "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Brazil" an overview of the pharmaceutical and medical device market of Brazil, including the market size; market segmentation by generic, Over-The-Counter (OTC), biologic and biosimilar products; and the key drivers and barriers for the market.

In depth, this report provides the following analysis -
- Covers the country’s reimbursement and payer landscape, as well as the regulatory landscape. The reimbursement and payer landscape section elaborates on the features of the healthcare reimbursement process for Brazil.
- Provides a detailed analysis of the political and economic environment of Brazil. It analyzes its economic indicators, demographics, healthcare infrastructure and healthcare expenditure.
- Provides an overview of the opportunities and challenges for growth that exist in the healthcare market of Brazil.

Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in Brazil, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market: Pfizer, Hypermarcas, Roche, Novartis and Sanofi and Profiles and SWOT analyses of the major players in the medical device market: Johnson & Johnson, B.Braun, Medtronic, Baxter and GSK.
- An insightful review of the reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the country’s political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the Brazil healthcare market

Reasons to buy
This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving Brazil’s healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Brazil’s healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Amrita helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Cellular Health Screening/Health Testing Market by Type, Multitest, Sample, Collection Site, and Region - Global Forecast to 2022

  • $ 9466
  • Industry report
  • July 2017
  • by MarketsandMarkets

“Cellular health screening market projected to grow at a CAGR of 10.0% from 2017 to 2022.” The global cellular health screening market is expected to reach USD 3.42 billion by 2022 from USD 2.12 billion ...

Mexico IVD Market Analysis

  • $ 3500
  • Industry report
  • July 2017
  • by Kalorama Information

In Mexico, there is a growing demand for new technologies in the laboratory sector and, as government and private hospital budgets increase, the market is expected to see an increase in demand for high-tech ...

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Germany

  • $ 1995
  • Industry report
  • May 2017
  • by GlobalData

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Germany Summary Germany has a mature healthcare market based on its high healthcare expenditure and pharmaceutical production. The increasingly ...


ref:plp2017

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.